Strategic partnership AJA Pharma has recently inked a strategic MoU with Remedica Ltd, signaling an active pursuit of regional collaboration and expanded manufacturing capabilities that could open co-development and supply opportunities for contract manufacturing, API sourcing, and joint ventures.

Regional footprint Operating from the Hail Industrial City with a state-of-the-art plant, AJA Pharma is positioned to serve the Saudi and broader Arab healthcare market, offering potential sales opportunities in fill/finish, formulation, and regulatory compliant production for regional distributors and multinational partners.

Growth potential With reported revenue in the mid five-figure million range and a scalable manufacturing base, there is upside for additional product lines, private label partnerships, and toll manufacturing agreements to expand portfolio breadth and geographic reach.

Sustainability and ethics AJA Pharma emphasizes environmental and ethical considerations in its operations, creating a selling point for partnerships with companies seeking compliant, responsible manufacturing and ESG-aligned supply chain collaborations.

Digital readiness Adoption of established tech stack and global standards suggests readiness to integrate supplier-quality portals, vendor management, and compliance workflows, enabling smoother onboarding of new customers and accelerated procurement cycles.